Company flags suspected price manipulation, seeks SEBI and BSE probe

Regulatory & Legal View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹97.49

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-4.8% vs market

Medical Equipment & Supplies peers, median of 13sector+0.0%-5.0% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 5.0 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-0.2-4.8+0.0-5.0

Next day

-2.6+0.1-2.7+1.0-3.7

-8.0+0.4-8.4+1.4-9.4

-4.6-0.6-4.0+1.9-6.5

-5.0-1.2-3.8+1.9-6.8

—-0.6—+1.8—

-5.1+0.5-5.6+0.8-5.9

15d

-1.5-0.2-1.2+1.1-2.6

+2.3-1.5+3.8-1.7+4.0

—-8.0—-7.6—

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Centenial Surgical Suture Ltd. has written to BSE and SEBI flagging suspected price manipulation in its shares. The company noted that on Aug 26, 2026, just 1 equity share traded and the price jumped 4.64 percent to Rs 97.49, and on Aug 21, 1 share traded pushing price up 4.99 percent to Rs 98.69. No corporate announcement or material change supported these moves. The company alleges pre-planned, circular trading by a syndicate of buyers spread across India and has attached detailed trading data covering Dec 2025 to Aug 2026. It requests an urgent investigation.

Likely market impact

May invite SEBI and BSE surveillance action on the scrip. Heightened risk of trading restrictions and sharp price swings if probe is launched.